XTL Biopharmaceuticals Statistics
Total Valuation
XTLB has a market cap or net worth of $11.10 million. The enterprise value is $10.07 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XTLB has 881.39 million shares outstanding. The number of shares has increased by 29.23% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 881.39M |
| Shares Change (YoY) | +29.23% |
| Shares Change (QoQ) | +22.96% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 749.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.61 |
| Forward PS | n/a |
| PB Ratio | 2.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 22.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61, with a Debt / Equity ratio of 0.03.
| Current Ratio | 0.61 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -77.57 |
Financial Efficiency
Return on equity (ROE) is -26.83% and return on invested capital (ROIC) is -34.84%.
| Return on Equity (ROE) | -26.83% |
| Return on Assets (ROA) | -24.74% |
| Return on Invested Capital (ROIC) | -34.84% |
| Return on Capital Employed (ROCE) | -34.24% |
| Revenue Per Employee | $64,429 |
| Profits Per Employee | -$146,714 |
| Employee Count | 7 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -130,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.22% in the last 52 weeks. The beta is 1.01, so XTLB's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -49.22% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 1.87 |
| Relative Strength Index (RSI) | 49.23 |
| Average Volume (20 Days) | 13,652 |
Short Selling Information
The latest short interest is 48,032, so 0.72% of the outstanding shares have been sold short.
| Short Interest | 48,032 |
| Short Previous Month | 54,079 |
| Short % of Shares Out | 0.72% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.04 |
Income Statement
In the last 12 months, XTLB had revenue of $451,000 and -$1.03 million in losses. Loss per share was -$0.00.
| Revenue | 451,000 |
| Gross Profit | 3,000 |
| Operating Income | -2.17M |
| Pretax Income | n/a |
| Net Income | -1.03M |
| EBITDA | -1.97M |
| EBIT | -2.17M |
| Loss Per Share | -$0.00 |
Full Income StatementBalance Sheet
The company has $1.14 million in cash and $138,000 in debt, giving a net cash position of $1.01 million or $0.00 per share.
| Cash & Cash Equivalents | 1.14M |
| Total Debt | 138,000 |
| Net Cash | 1.01M |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 5.44M |
| Book Value Per Share | 0.01 |
| Working Capital | -867,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.62 million and capital expenditures -$54,000, giving a free cash flow of -$1.67 million.
| Operating Cash Flow | -1.62M |
| Capital Expenditures | -54,000 |
| Free Cash Flow | -1.67M |
| FCF Per Share | -$0.00 |
Full Cash Flow StatementMargins
Gross margin is 0.67%, with operating and profit margins of -481.60% and -227.72%.
| Gross Margin | 0.67% |
| Operating Margin | -481.60% |
| Pretax Margin | -256.54% |
| Profit Margin | -227.72% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |